<DOC>
	<DOCNO>NCT02558478</DOCNO>
	<brief_summary>Next Generation Sequencing ( NGS ) strategy powerful tool identify gene implicate rare disease previous genetic exploration remain negative date . The aim project base group patient original clinical phenotype include neurosensory impairment without genetic cause identify date . The investigator study family use whole exome sequence potentially identify new gene new underlie biological pathway involve neurosensory disease .</brief_summary>
	<brief_title>Identification New Genes Implicated Rare Neurosensory Diseases Whole Exome Sequencing</brief_title>
	<detailed_description />
	<mesh_term>Hearing Loss</mesh_term>
	<criteria>Original phenotype neurosensory disease Written , inform consent obtain Refusal participate study Prior inclusion similar study ( NGS )</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>December 2016</verification_date>
	<keyword>Whole exome sequencing</keyword>
</DOC>